[1] 梁晓峰.实现无脊髓灰质炎后中国免疫规划工作现况分析[J].中国计划免疫, 2005, 11(5): 333-338. [2] 崔惠, 唐海淑, 郭强, 等.新疆维吾尔自治区2012年脊髓灰质炎病毒学监测结果和分析[J].中国疫苗和免疫, 2015, 21(1): 29-31. [3] 马论文.2011~2012年新疆阿合奇县脊髓灰质炎疫苗应急强化免疫效果分析[J].疾病预防控制通报, 2013, 28(2): 78-79. [4] GNANASHANMUGAM D, TROY S B, MUSINGQINI G, et al.Immunologic response to oral polio vaccine in human immunodeficiency virus-infected and uninfected zimbabwean children[J].Pediatr Infect Dis J, 2012, 31(2): 176-180.DOI:10.1097/INF.0b013e31823faa5f. [5] KIM H J, HWANG S, LEE S, et al.A national cross-sectional study for poliovirus seroprevalence in the Republic of Korea in 2012: implication for deficiency in immunity to polio among middle-aged people[J].Bmc Infect Dis, 2015, 15: 164.DOI:10.1186/s12879-015-0894-z. [6] VANCELIK S, GURAKSIN A, AYYILDIZ A, et al.Seroepidemiology of poliovirus antibody among the children in Eastern Turkey[J].Indian J Med Res, 2007, 126(6): 528-533. [7] TROY S B, KOUIAVSKAIA D, SIIK J, et al.Comparison of the immunogenicity of various booster doses of inactivated polio vaccine delivered intradermally versus intramuscularly to HIV-infected adults[J].J Infect Dis, 2015, 211(12): 1969-1976.DOI:10.1093/infdis/jiu841. [8] 赵春芳, 王青, 徐佳薇, 等.重庆市2012年健康人群脊髓灰质炎抗体水平监测分析[J].中国疫苗和免疫, 2013, 19(5): 417-443. [9] NORTON E B, BAUER D L, WELDON W C, et al.The novel adjuvant dmLT promotes dose sparing, mucosal immunity and longevity of antibody responses to the inactivated polio vaccine in a murine model[J].Vaccine, 2015, 33(16): 1909-1915.DOI:10.1016/j.vaccine.2015.02.069. [10] 刘桂艳, 王丽霞, 常新, 等.吉林省边境地区健康人群脊髓灰质炎中和抗体水平的监测[J].中国疫苗和免疫, 2009, 15(3): 249-250. [11] NASIR U N, BANDYOPADHYAY A S, MONTAGNANI F, et al.Polio elimination in Nigeria: A review[J].Hum Vacc Immunother, 2016, 12(3): 658-663.DOI:10.1080/21645515.2015.1088617. [12] 黄利明, 许二萍, 祝水芬, 等.杭州市人群脊髓灰质炎抗体水平监测结果[J].浙江预防医学, 2008, 20(2): 13-18. [13] YANG C T, SHI H Y, ZHOU J, et al.CpG oligodeoxynucleotides are a potent adjuvant for an inactivated polio vaccine produced from Sabin strains of poliovirus[J].Vaccine, 2009, 27(47): 6558-6563.DOI:10.1016/j.vaccine.2009.08.047. [14] 马文军, 王涛, 牛桓彩.北京市昌平区健康人群脊髓灰质炎抗体水平分析[J].中国卫生检验杂志, 2013, 23(3): 755-756. [15] WESTDIJK J, BRUGMANS D, MARTIN J, et al.Characterization and standardization of Sabin based inactivated polio vaccine: Proposal for a new antigen unit for inactivated polio vaccines[J].Vaccine, 2011, 29(18): 3390-3397.DOI:10.1016/j.vaccine.2011.02.08. |